Clinical Significance of Gastrointestinal and Flushing Events in Patients with Multiple Sclerosis Treated with Delayed-Release Dimethyl Fumarate

Background: In the phase 3 DEFINE and CONFIRM trials, flushing and gastrointestinal (GI) events were associated with delayed-release dimethyl fumarate (DMF; also known as gastroresistant DMF) treatment in people with relapsing-remitting multiple sclerosis (MS). To investigate these events, a post ho...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J MS Care
Main Authors: Phillips, J. Theodore, Selmaj, Krzysztof, Gold, Ralf, Fox, Robert J., Havrdova, Eva, Giovannoni, Gavin, Abourjaily, Heather, Pace, Amy, Novas, Mark, Hotermans, Christophe, Viglietta, Vissia, Meltzer, Leslie
Formato: Artigo
Idioma:Inglês
Publicado em: The Consortium of Multiple Sclerosis Centers 2015
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4599361/
https://ncbi.nlm.nih.gov/pubmed/26472945
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7224/1537-2073.2014-069
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados